Author Archives: gliffen

Nadia Blanchet, M.D. Elected as Associate Editor to the Editorial Board of PRS Global Open.

Dear Dr. Blanchet,

At the most recent Plastic and Reconstructive Surgery- Global Open (PRS Global Open) Managing Committee and Editorial Board meetings held in October 2017 in Orlando, Florida, you were nominated and elected as an Associate Editor to the Editorial Board of PRS Global Open. Your nomination and election has been subsequently forwarded to the ASPS Executive Committee. They have approved your selection, and you are now an official member of the Editorial Board of PRS Global Open. Congratulations! Your term will begin and your name will appear on the masthead on January 1, 2018.

Plastic and Reconstructive Surgery – Global Open is the international open access journal of the American Society of Plastic Surgeons, aiming to improve patient safety, care, and outcomes one open access article at a time. The journal is an online-only open access publication, aimed at improving patient safety, outcomes, and care one open access article at a time; it launched in April 2013 and has surpassed all of our expectations. PRS Global Open has won several national publishing awards and is indexed by ESCI, a new edition of Web of Science, as well as SCOPUS. This is already a fast-growing, increasingly impactful, global platform for plastic surgery; and we’re only just beginning.

Your term as Associate Editor will last 3 years. At the end of your term, depending upon your willingness, performance as a reviewer, and the needs of the Journal, you can be re-elected to a second 3-year term. As an Editorial Board member, your responsibilities will include:

  • Service as a high-volume peer reviewer for PRS Global Open (and PRS as well)
    • Approximately 1 – 3 per month as discussed;
    • Agree to review no less than 70% of the articles I invite you to complete;
    • Complete approximately 90% of the articles you agree to review;
    • Aim to submit each review on or before the deadline; be no more than 5 days late;
  • Keep your personal classifications up to date in
    • we cannot properly invite you to review manuscripts in your areas of expertise without up-to-date classifications
  • Optional attendance at the Editorial Board meetings, held at the ASPS Annual Meeting;
  • Participation in Ad Hoc Committees which conduct studies and implement new initiatives for the Journal;
  • Become a “PRS Global Open” ambassador: read and share articles via social networks, promote the Journal;
    • An “ambassador kit” will be provided to aid in your understanding and promotion of the journal;
  • Provide assistance with special projects upon request, such as building collections or generating article topics;
  • Read, Share, Download, Email, Watch, and Engage with PRS Global Open content on;
  • Help promote the journal and journal articles via social media (especially Facebook, Instagram, and Twitter);
    • Let me know your ‘handle’ as soon as possible
    • Use “#PRSGlobalOpen” on Twitter or Instagram
    • A Social Media Digest is prepared and sent weekly to Editorial Board Members to make the process easier
  • Consider submitting manuscripts to PRS Global Open if you have not already done so.

We do not anticipate these responsibilities to become burdensome upon you. We, along with the entire Board, are pleased to greet you as a member, and we look forward to working with you more closely on Journal-related issues in the years to come. Please let us know if you do not accept this position.

Best regards,

Rod J. Rohrich, M.D.

James M. Stuzin, M.D.

Vivace Microneedling – The Hottest Trend in Aesthetics

Introducing Vivace Microneedling

Introducing the newest generation of microneedling with radio frequency built to improve the contouring and tightening for the face, neck, hands, and body and to produce immediate, pain-free results.


vivace microneedlingThe Vivace Difference:

-Insulated and non-insulated gold-tipped needles for ultimate versatility

-Robotic arm & depth settings down to 3.5mm at .1mm increments – more precise than any other RF micro-needling device

-Even delivery of radiofrequency

-Red and Blue LED

-Clear microchannels remain open for four to six hours – offers ideal conditions for PRP and other supplemental topicals


Learn more about Vivace

“This is probably one of the most remarkable devices I’ve seen come along and truly energize our practice in the past 25 years. 
Without a doubt, it is the most comfortable client experience, with minimal or no downtime”

–  Dr. David B. Vasily, MD, FAAD

“There is always a risk with light-based technology. With Vivace, we redefine no downtime and give patients the results, pain-free experience, and instant gratification the market is demanding today – Simply put, what most lasers can not offer.”

– Dr. Paul Glat, MD 

BFACE: A Framework for Evaluating Breast Aesthetics

Summary: Although much has been written about breast aesthetics, the literature lacks a simple yet systematic and comprehensive approach for pre-operative breast assessment. With use of the mnemonic “BFACE,” the breast surgeon will analyze the bony skeleton and the breast footprint, areola, conus, and envelope. The authors present a thorough review of the important parameters that define the ideal breast, and several techniques for perceiving asymmetries more clearly. Strategic surgical planning is enabled by accurate perception.

(Plast. Reconstr. Surg. 140: 287e, 2017.)

Click Here to read the full article.

Safety of nipple sparing mastectomy

Some patients are worried about the safety of saving the nipple. The advantages are keeping the nipple , a hidden scar and a prettier shape. I also find that these patients tend to be less depressed after their surgery. Your mastectomy surgeon will decide if this is a safe option for you, but some patients continue to have some lingering doubts. Below is the latest evidence in favor of nipple sparing mastectomy safety.

‘Nipple-Sparing’ Mastectomies Don’t Raise Odds of Cancer’s Return: Study

Research suggests that the cosmetically superior procedure comes with no added risk

By Robert Preidt, HealthyDay Reporter

WEDNESDAY, July 19, 2017 (HealthDay News) — Surgeons performing mastectomies can offer a form of the procedure that allows women to retain the nipple for use in breast reconstruction.

Now, a reassuring study finds that this type of mastectomy doesn’t raise a woman’s risk for breast cancer recurrence.

“More women are requesting nipple-sparing mastectomy because of the superior cosmetic results. But doctors don’t want to take any chances with breast cancer patients’ safety for the sake of cosmetic improvement,” explained lead researcher Dr. Barbara Smith. She’s a surgical oncologist and director of the breast program at Massachusetts General Hospital in Boston.

“Our study, which has one of the longest reported follow-ups after therapeutic nipple-sparing mastectomy in the United States, provides additional support that it’s safe to leave the nipple intact during mastectomy with only a few exceptions,” she said in a news release from the Journal of the American College of Surgeons. It published the findings online July 17.

Most breast cancer patients are eligible for nipple-sparing mastectomy, which leaves the natural nipple in place. That’s different from a standard mastectomy, where the whole breast and breast skin, including the nipple, are removed.

Nipple-sparing mastectomy has several advantages over standard mastectomy, Smith said.

“Often, a woman feels more whole when she keeps her nipple,” she said. “Not only does the breast look more natural after [the surgery], a woman who still has fully intact breast skin can often choose to have a single-stage breast reconstruction with an implant, rather than needing a tissue expander (an inflatable breast implant) to stretch the skin over several months.”

In the new study, Smith’s team tracked outcomes for 297 women who underwent nipple-sparing mastectomy from June 2007 through 2012. Fourteen had cancer in both breasts and underwent nipple-sparing mastectomy on both sides, so the total number of surgeries was 311.

After a median follow-up of more than four years, there was a 5.5 percent breast cancer recurrence rate. None of the recurrences involved nipples retained during mastectomies, the findings showed.

The cancer recurrence rate among patients in this study was comparable to rates seen after standard mastectomy, Smith said.

Two breast cancer surgeons said the new findings should help women feel good about nipple-sparing mastectomy.

The study “encourages those of us who have been waiting for long-term results to now incorporate the procedure into our practices,” said Dr. Virginia Maurer, who directs breast surgery at NYU Winthrop Hospital in Mineola, N.Y. She said the hospital has already been offering women these surgeries “for five years with good results.”

Dr. Lauren Cassell is chief of breast surgery at Lenox Hill Hospital in New York City. She agreed that “nipple-sparing mastectomies offer our patients a cosmetic approach which allows them to look most like themselves, not to mention avoiding an additional procedure to recreate a nipple.”

However, “patients as well as physicians have been wary about the possible increased risk of local recurrence in the nipple areola complex,” Cassell said. But the Boston study appears to have laid those fears to rest, she noted.

More information

The American Cancer Society has more on breast cancer surgery.

SOURCES: Virginia Maurer, M.D., chief, division of breast surgery, NYU Winthrop Hospital, Mineola, N.Y.; Lauren Cassell, M.D., chief of breast surgery, Lenox Hill Hospital, New York City; Journal of the American College of Surgeons, news release, July 17, 2017


Reelevating the Mastectomy Flap: A Safe Technique for Improving Nipple-Areolar Complex Malposition after Nipple-Sparing Mastectomy

Summary: Nipple-areolar complex (NAC) malposition is one of the most common complications following nipple-sparing mastectomy with implant-based reconstruction. To maximize perfusion to the NAC, traditional methods of correcting NAC malposition limit undermining below the NAC. We demonstrate a series of cases in which improvement of NAC malposition was safely performed by reelevating the NAC and mastectomy flap to allow redraping of the soft tissue envelope over the implant and the overlying capsule. Thirty-four patients were identified in a span over 4 years where 44 NACs were repositioned using this method. There was zero incidence of postoperative ischemia or necrosis of the NAC or mastectomy flaps. There was noticeable improvement in the NAC position on the breast mound. Reelevation of the mastectomy skin flap to correct malposition of the NAC after nipple-sparing mastectomy is a safe and effective option, avoids additional scars, and can be performed more than once to further improve positioning of the NAC.

Click Here to read the full article

Animation Deformity in Postmastectomy Implant-Based Reconstruction

Animation deformity (AD), including its prevalence and effect on patients, has been studied in the context of subpectoral augmentation mammaplasty.1 However, to our knowledge, only 1 other study has defined the prevalence and effect of AD in the subpectoral implant-based breast reconstruction patient population.2 Given the recent rise in prepectoral, implant-based reconstruction, an assessment of patient experience with AD in the partial subpectoral implant-based reconstruction population is timely and relevant.

Click Here to read the full article

Bioengineered Breast: Concept, Technique, and Preliminary Results

We read with interest the article titled “Bioengineered Breast: Concept, Technique, and Preliminary Results” by Maxwell and Gabriel. The concept of “bioengineering” the breast using acellular dermal matrix and fat grafting has revolutionized prosthetic-based reconstruction; the authors’ contribution to the literature in this field is significant. The authors detail their method using acellular dermal matrix and fat grafting to augment the soft-tissue envelope in breast reconstruction during the second stage of breast reconstruction.

Click Here to read the full article.

Abdominoplasty Pain Study

I am pleased to announce that our practice has received Institutional Review Board approval to conduct a study to see if we can help improve abdominal pain after abdominoplasty. Participation in the study is completely optional.

Dysport is a medication similar to Botox in that it helps to weaken muscles temporarily. We are hoping that an injection of Dysport at the time of surgery will help the muscle spasm and tightness that patients usually feel after this surgery for several weeks to months. The dose given will not be enough to interfere with normal activities or exercise.

We have used Dysport on a few patients, and because we were so impressed with their decreased pain, decided to embark on this study. Patients will be randomized, which means they will either receive the Dysport or not. The Dysport injection is about a $500 value and will be given at no cost to the patient. All patients will be asked to keep a pain log for several months, and then we will see if we can detect a difference in the patients who received the Dysport with those who did not.

We are very excited about this research opportunity, but if it is not something you are interested in, you do not need to participate in the study.